$heff's $tation of $tocks & $olid DD

[$heff]

alexed...w/ CRXX ($1.42)..that information definitely needs to be considered. That is why you play the FDA approval piece as I don't expect to hold this long-term. I see it as a solid trade. I look forward to the price appreciation that I expect to see in the shares in the week to come. Appreciate the info.

Message in reply to:

“CRXX and Neuromed Pharmaceuticals Inc. yesterday announced that they have merged, combining the product assets and financial resources of both organizations, including potential Exalgo(TM) milestone and royalty revenue, CRXX's portfolio of product candidates and unique drug discovery capabilities. The combined company will trade under the stock symbol "CRXX" on the NASDAQ Global Market. … Under the merger agreement, CRXX issued approximately 14.9 million new shares of its common stock to Neuromed stockholders and placed another approximately 67.8 million new shares of its common stock in escrow. Escrow shares will be released in whole or in part to former Neuromed stockholders based upon the outcome and timing of the FDA's review of the New Drug Application (NDA) of the product candidate Exalgo, which has a February 22, 2010, PDUFA review date.”